Lymphangioleiomyomatosis

MedGenMed Medscape General Medicine

Volumn 8, Issue 1, 2006, Pages

  McCormack, Francis X ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GONADORELIN; MEDROXYPROGESTERONE ACETATE; PROTEIN KINASE B;

AIRWAY OBSTRUCTION; ARTICLE; BLOOD VESSEL OCCLUSION; CELL GROWTH; CELL INFILTRATION; CHYLOTHORAX; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; FREQUENCY ANALYSIS; GENE TARGETING; GENETIC ANALYSIS; HUMAN; LABORATORY TEST; LUNG STRUCTURE; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PNEUMOTHORAX; RARE DISEASE; RESPIRATORY FAILURE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THORAX RADIOGRAPHY; GENETICS; REVIEW;

HUMANS; LYMPHANGIOLEIOMYOMATOSIS;

EID: 32544445719     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lutembacher R. Dysembryomes metatypiques des reins; carcinose submiliaire aigue du poumon avec emphyseme generalise et double pneumothorax. Ann Med. 1918;5:435-450.
2. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc. 2000;75:591-594. Abstract.
3. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med. 2001;164:661-668. Abstract
4. Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001;164.669-671.Abstract
5. Aubry MC, Myers JL, Ryu JK et al. Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med. 2000;162(2 Pt 1):749-752.
6. Kim NR, Chung MP, Park CK, Lee KS, Han J. Pulmonary lymphangioleiomyomatosis and multiple hepatic angiomyolipomas in a man. Pathol Int. 2003;53:231-235. Abstract
7. von Stossel E. Uber muskulare Cirrhose der Lunge (Muscular cirrhosis of the lung). Beitr Klin Tuberk. 1937;90:432-442.
8. Sullivan EJ, Beck GJ, Peavy HH, Fanburg BL. Lymphangioleiomyomatosis Registry. Chest. 1999;115:301.
9. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2005;37:19-24. Abstract
10. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1:157-162. Abstract
11. Astrinidis A, Khare L, Carsillo T, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000;37:55-57. Abstract
12. Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP. Evidence that lymphangiomyomatosis is caused by TSC2Mutations: Chromosome l6p13 loss of beterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet. 1998;62.810-815. Abstract
13. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA. 2000;97:6085-6090. Abstract
14. Karbowniczek M, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med. 2003;167:976-982. Abstract
15. Henske EP. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer. 2001;38:376-381.
16. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 2001;105:345-355. Abstract
17. Potter CY, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 2001;105:357-368. Abstract
18. Gao X, Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 2001;15:1383-1392. Abstract
19. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol. 2003;5:578-581. Abstract
20. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol. 2003;5:566-571. Abstract
21. Garami A, Zwartkruis FJ, Nobukuni T, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell. 2003;11:1457-1466. Abstract
22. Brugarolas J, Lei Y, Hurley RL, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004;18:2893-2904. Abstract
23. Brugarolas J, Kaelin WG Jr. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell. 2004;6:7-10. Abstract
24. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell. 2001;4:147-158.
25. Kumasaka T, Seyarna K, Mitani K, et al. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol. 2004;28:1007-1016. Abstract
26. Sullivan EJ. Lymphangioleiomyomatosis: A review. Chest. 1998;114:1689-1703. Abstract
27. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax. 2000;55:1052-1057. Abstract
28. Kitaichi M, Nishimura K, Itoh H, Izzumi T. Pulmonary lymphangioleiomyomatosis: A report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995;151:527-533. Abstract
29. Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM P). Medicine (Baltimore). 1999;78:321-337. Abstract
30. Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest. 2003;123:623-627. Abstract
31. Muir TE, Leslie KO, Popper H, et al. Micronodular pneumocyte hyperplasia. Am J Surg Pathol. 1998;22:465-472. Abstract
32. Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 1999;115:1041-1052. Abstract
33. Burger CD, Hyatt RE, Staats BA. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis. 1991;143(5 Pt 1):1030-
34. Crausman RS, Jennings CA, Mortenson RL, Ackerson LM, Irvin CG, King TE Jr. Lymphangioleiomyomatosis: the Pathophysiology of diminished exercise capacity. Am J Respir Crit Care Med. 1996;153(4 Pt 1):1368-1376.
35. Koyama M, Johkoh T, Honda O, et al. Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol. 2001;180:827-835.
36. Bernstein SM, Newell Jr JD, Adamczyk D, Mortensen R, King Jr TE, Lynch DA. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomittosis? Am J Respir Crit Care Med. 1995;152:2138-2143.
37. Carrington CB, Cugell DW, Gaensler EA, et al. Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis. 1977;116:977-995. Abstract
38. Corrin B, Leibow AA, Friedman PJ. Pulmonary lymphangiomyomatosis: a review. Am J Pathol. 1975;79:348-382. Abstract
39. Matsui K, Hilbert SL, Yu ZX, et al. Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med. 2000;124:1642-1648. Abstract
40. Matsumoto Y, Horiba K, Usuki J, Chu SC, Ferrans VJ, Moss J. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol. 1999;21:327-336. Abstract
41. Hoon V, Thung SN, Kaneko M, Unger PD. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med. 1994;118:732-734. Abstract
42. McCarty KS Jr, Mossler JA, McLelland R, Sieker HO. Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med. 1980;303:1461-1465. Abstract
43. Colley MH, Geppert E, Franklin WA. Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis. Am J Surg Pathol. 1989;13:803-807. Abstract
44. Berger U, Khaghani A, Pomerance A, Yacoub MH, Coombes RC. Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study. Am J Clin Pathol. 1990;93:609-614. Abstract